Literature DB >> 16936560

Body fat changes and lipodystrophy in HIV-infected children: impact of highly active antiretroviral therapy.

Agnieszka B Dzwonek, Margaret S Lawson, Tim J Cole, Vas Novelli.   

Abstract

Entities:  

Mesh：

Year:  2006        PMID： 16936560     DOI： 10.1097/01.qai.0000230523.94588.85

Source DB:  PubMed          Journal:  J Acquir Immune Defic Syndr        ISSN： 1525-4135            Impact factor:   3.731


× No keyword cloud information.
  10 in total

1.  New drugs approved in 2010.

Authors:  Erin Sears; Tegan Steimel
Journal:  Proc (Bayl Univ Med Cent)       Date:  2011-04

2.  High Prevalence of Dyslipidemia and Insulin Resistance in HIV-infected Prepubertal African Children on Antiretroviral Therapy.

Authors:  Steve Innes; Kameelah L Abdullah; Richard Haubrich; Mark F Cotton; Sara H Browne
Journal:  Pediatr Infect Dis J       Date:  2016-01       Impact factor: 2.129

3.  Metabolic abnormalities and body composition of HIV-infected children on Lopinavir or Nevirapine-based antiretroviral therapy.

Authors:  Stephen Arpadi; Stephanie Shiau; Renate Strehlau; Leigh Martens; Faeezah Patel; Ashraf Coovadia; Elaine J Abrams; Louise Kuhn
Journal:  Arch Dis Child       Date:  2012-12-05       Impact factor: 3.791

4.  Biceps skin-fold thickness may detect and predict early lipoatrophy in HIV-infected children.

Authors:  Steve Innes; Eva Schulte-Kemna; Mark F Cotton; Ekkehard Werner Zöllner; Richard Haubrich; Hartwig Klinker; Xiaoying Sun; Sonia Jain; Clair Edson; Margaret van Niekerk; Emily Ryan Innes; Helena Rabie; Sara H Browne
Journal:  Pediatr Infect Dis J       Date:  2013-06       Impact factor: 2.129

5.  Improvement in lipids after switch to boosted atazanavir or darunavir in children/adolescents with perinatally acquired HIV on older protease inhibitors: results from the Pediatric HIV/AIDS Cohort Study.

Authors:  J Jao; W Yu; K Patel; T L Miller; B Karalius; M E Geffner; L A DiMeglio; A Mirza; J S Chen; M Silio; E J McFarland; R B Van Dyke; D Jacobson
Journal:  HIV Med       Date:  2017-11-21       Impact factor: 3.180

6.  Nutritional status and lipid profile of HIV-positive children and adolescents using antiretroviral therapy.

Authors:  Patricia Viganó Contri; Erica Miranda Berchielli; Marina Hjertquist Tremeschin; Bento Vidal de Moura Negrini; Roberta Garcia Salomão; Jacqueline Pontes Monteiro
Journal:  Clinics (Sao Paulo)       Date:  2011       Impact factor: 2.365

7.  Components of metabolic syndrome associated with lower neurocognitive performance in youth with perinatally acquired HIV and youth who are HIV-exposed uninfected.

Authors:  Stephanie Shiau; Wendy Yu; Denise L Jacobson; Sharon Nichols; Elizabeth J McFarland; Janet S Chen; Sahera Dirajlal-Fargo; Karen Surowiec; Mitchell E Geffner; Jennifer Jao
Journal:  J Neurovirol       Date:  2021-09-15       Impact factor: 2.643

8.  Virtual support for paediatric HIV treatment decision making.

Authors:  Kirsty Le Doare; N E Mackie; S Kaye; A Bamford; S Walters; C Foster
Journal:  Arch Dis Child       Date:  2014-12-30       Impact factor: 3.791

9.  High prevalence of lipoatrophy in pre-pubertal South African children on antiretroviral therapy: a cross-sectional study.

Authors:  Steve Innes; Mark F Cotton; Richard Haubrich; Maria M Conradie; Margaret van Niekerk; Clair Edson; Helena Rabie; Sonia Jain; Xiaoying Sun; Ekkehard W Zöllner; Stephen Hough; Sara H Browne
Journal:  BMC Pediatr       Date:  2012-11-23       Impact factor: 2.125

10.  Lipoatrophy/lipohypertrophy outcomes after antiretroviral therapy switch in children in the UK/Ireland.

Authors:  Steve Innes; Justin Harvey; Intira Jeannie Collins; Mark Fredric Cotton; Ali Judd
Journal:  PLoS One       Date:  2018-04-04       Impact factor: 3.240
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.